IgA肾病患者的妊娠与肾脏结局:一项队列研究
该队列研究纳入2003年12月至2014年9月活检的413例育龄期IgA肾病女性,随访至少1年。随访期间104例共116次妊娠,110次持续超过20周。校正年龄、eGFR、平均动脉压、蛋白尿和病理分级后,CKD 3~4期患者妊娠与更快的eGFR下降(-7.44 vs -3.90 mL/min/1.73m²/年,P=0.007)及肾脏进展事件增加(HR 5.14,95%CI 1.16~22.74)相关,而CKD 1~2期无此关联。
要点
- CKD 3~4期IgA肾病患者妊娠与更快的eGFR下降相关(-7.44 vs -3.90 mL/min/1.73m²/年,P=0.007)。
- CKD 3~4期IgA肾病患者妊娠与肾脏进展事件增加相关(HR 5.14,95%CI 1.16~22.74)。
- CKD 1~2期IgA肾病患者妊娠与肾脏病进展无显著关联。
核心结论
- 妊娠加速CKD 3期IgA肾病女性的肾脏病进展,但在CKD 1期或2期患者中未见此效应。
研究设计与样本
- 队列研究,纳入2003年12月至2014年9月活检、随访至少1年的育龄期IgA肾病女性413例。
- 妊娠作为时间依赖变量,基线(活检时)预测因素包括eGFR、蛋白尿、血压和肾脏病理(牛津MEST分类)。
主要发现
- 413例中CKD 1、2、3、4期分别为266例(64.4%)、101例(24.5%)、40例(9.6%)、6例(1.5%)。
- 随访期间104例共116次妊娠,其中110次持续超过20周;309例未妊娠。
- 校正年龄、eGFR、平均动脉压、蛋白尿和活检时病理分级后,CKD 3~4期患者妊娠与更快的eGFR下降相关(-7.44 vs -3.90 mL/min/1.73m²/年,P=0.007)。
- CKD 3~4期患者妊娠与肾脏进展事件增加相关(HR 5.14,95%CI 1.16~22.74),CKD 1~2期患者无此关联。
局限性
- 样本量相对较小,且为单中心经验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The outcomes of pregnancy in immunoglobulin A nephropathy (IgAN) are controversial. This cohort study assessed the effects of pregnancy on kidney disease progression and risk factors for adverse pregnancy outcomes in patients with IgAN. STUDY DESIGN: A cohort study. SETTING & PARTICIPANTS: Women of child-bearing age with IgAN and minimum follow-up of 1 year after biopsy from December 2003 to September 2014. PREDICTORS: Pregnancy, treated as a time-dependent variable; baseline (at time of biopsy) estimated glomerular filtration rate (eGFR), proteinuria, blood pressure, and kidney pathology (Oxford MEST classification). OUTCOMES: Kidney disease progression event, defined as 30% decline in eGFR or end-stage kidney disease; rate of eGFR decline; and adverse pregnancy outcomes, including severe preeclampsia and fetal loss. RESULTS: Of 413 patients enrolled, 266 (64.4%), 101 (24.5%), 40 (9.6%), and 6 (1.5%) had chronic kidney disease (CKD) stages 1, 2, 3, and 4, respectively. During follow-up, 104 had 116 pregnancies, of which 110 continued beyond week 20; 309 patients did not become pregnant. After adjustment for age, eGFR, mean arterial pressure, proteinuria, and pathology class at the time of biopsy, subsequent pregnancy among patients with CKD stages 3 to 4, but not CKD stages 1 to 2, was associated with faster eGFR decline (-7.44 vs -3.90mL/min/1.73m2 per year; P=0.007) and increased incidence of kidney progression events (HR, 5.14; 95% CI, 1.16-22.74) compared with patients who did not become pregnant. LIMITATIONS: Relatively small sample size and single-center experience. CONCLUSIONS: Pregnancy accelerated kidney disease progression in women with IgAN and CKD stage 3, but not in those at stage 1 or 2.
引用
- Su X, Lv J, Liu Y, et al. Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study. Am J Kidney Dis. 2017. PMID: 28320554. doi:10.1053/j.ajkd.2017.01.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。